Brain Advance Access originally published online on September 26, 2006
Brain 2007 130(1):120-133; doi:10.1093/brain/awl260
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The adult form of Niemann–Pick disease type C
1 Assistance Publique-Hôpitaux de Paris, Fédération des maladies du système nerveux Paris 2 Unité mixte de recherche INSERM U-711, UPMC, Hôpital de la Salpêtrière Paris 3 Centre de référence, Maladies Lysosomales à Expression Neurologique Paris 4 Hospices Civils de Lyon, Laboratoire Gillet-Mérieux, Centre Hospitalier Lyon-Sud, Pierre-Bénite Lyon, France 5 INSERM Unité 499, Faculté de Médecine Laënnec Lyon, France 6 Permanent address: Consultation de Génétique, Hopital Debrousse Lyon, France
Correspondence to: Marie T. Vanier, MD PhD, Laboratoire Gillet-Mérieux, Bâtiment 3B, Centre Hospitalier Lyon-Sud, 69495 Pierre-Bénite cedex, France E-mail: vanier{at}lyon.inserm.fr
Niemann–Pick disease type C (NPC) is a fatal neurovisceral lipid storage disease of autosomal inheritance resulting from mutations in either the NPC1 (95% of families) or NPC2 gene. The encoded proteins appear to be involved in lysosomal/late endosomal transport of cholesterol, glycolipids and other molecules but their exact function is still unknown. The clinical spectrum of the disease ranges from a neonatal rapidly fatal disorder to an adult-onset chronic neurodegenerative disease. Based upon a comprehensive study of 13 unrelated adult patients diagnosed in France over the past 20 years as well as the analysis of the 55 other cases published since 1969, we have attempted to delineate the major clinical, radiological, biochemical and genotypic characteristics of adult NPC. Overall, mean age at onset (±SD) of neuropsychiatric symptoms was 25 ± 9.7 years. The diagnosis of NPC was established after a mean delay of 6.2 ± 6.4 years and the mean age at death (calculated from 20 cases) was 38 ± 10.2 years. Major clinical features included cerebellar ataxia (76%), vertical supranuclear ophthalmoplegia (VSO, 75%), dysarthria, (63%), cognitive troubles (61%), movement disorders (58%), splenomegaly (54%), psychiatric disorders (45%) and dysphagia (37%). Less frequent signs were epilepsy and cataplexy. During the course of the disease, clinical features could be subdivided into (i) visceral signs (hepatomegaly or splenomegaly), (ii) cortical signs (psychiatric cognitive disorders and epilepsy); and (iii) deep brain signs (VSO, ataxia, movement disorders, dysarthria, dysphagia, cataplexy) which exhibited different evolution patterns. Asymptomatic and non-evolutive visceral signs were often noticed since early childhood (38.5% of our patients), followed by mild cortical signs in childhood (learning difficulties) and early adulthood (62% of cases among which 38% were psychiatric disorders). Deep brain signs were observed in 96% of patients and were usually responsible for death. In general, there was a good correlation between clinical signs and the localization of brain atrophy on MRI. The ‘variant’ biochemical phenotype characterized by mild abnormalities of the cellular trafficking of endocytosed cholesterol was over-represented in the adult form of NPC and seemed associated with less frequent splenomegaly in childhood and lesser psychiatric signs. Involvement of the NPC1 gene was shown in 33 families and of the NPC2 gene in one. Improving the knowledge of the disease among psychiatrists and neurologists appears essential since emerging treatments should be more efficient at the visceral or cognitive/psychiatric stages of the disease, before the occurrence of widespread deep brain neurological lesions.
Key Words: adult; inborn errors of metabolism; lysosome; Niemann–Pick C
Abbreviations: NPC, Niemann–Pick disease type C; VSO, vertical supranuclear ophthalmoplegia
Received July 16, 2006. Revised August 16, 2006. Accepted August 18, 2006.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M.-D. Wang, V. Franklin, M. Sundaram, R. S. Kiss, K. Ho, M. Gallant, and Y. L. Marcel Differential Regulation of ATP Binding Cassette Protein A1 Expression and ApoA-I Lipidation by Niemann-Pick Type C1 in Murine Hepatocytes and Macrophages J. Biol. Chem., August 3, 2007; 282(31): 22525 - 22533. [Abstract] [Full Text] [PDF]
|
|